Your browser doesn't support javascript.
loading
Level 3 Axillary Nodal Status in the Absence of Metastatic Disease in Level 1 and 2 Axillary Node in Carcinoma Breast – A Retrospective Analysis
Article | IMSEAR | ID: sea-209296
ABSTRACT

Introduction:

The intention of axillary lymph node dissection (ALND) is to stage the axilla precisely for prognostic information.This study is to assess the possibility of skip lesion in Level 3 in the absence of disease in Level 1 and 2 which may help inundertaking randomized controlled study to avoid Level 3 nodal dissection in our patients.Materials and

Methods:

Retrospective analysis of 60 patients who underwent surgery for invasive breast cancer from October2013 to October 2019 in the Department of Surgical Oncology, Government Thoothukudi Medical College Hospital, Thoothukudi,was performed.

Results:

About 33.3% of patients (20) were disease free in the axilla and the remaining 66.7% (40) had nodal involvement. Ofthose 39 patients who had nodal involvement in Level 1 and 2, 15 were found to have the disease in 4 or more nodes, 24 hadthe disease in <4 nodes. Totally 16 patients had metastases in Level 3 nodes. There is a 60% chance of involvement of Level3 when there is 4 or more nodal positivity in Level 1 and 2 and it drops to 25% if the involved nodal count becomes <4. Onepatient had skip lesion in Level 3 (4.8%) without disease in Level 1 and 2.

Conclusion:

Since there has been a dearth of randomized studies about levels of nodes to be addressed in ALND and studiesabout skip lesion in Level 3 from our country, we urge the need for more studies probably multicentric, regarding the extent ofALND. Until then, it may be fruitful to do complete ALND up to Level 3 for the better staging of the axilla.

Full text: Available Index: IMSEAR (South-East Asia) Type of study: Controlled clinical trial Year: 2020 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: IMSEAR (South-East Asia) Type of study: Controlled clinical trial Year: 2020 Type: Article